强制瓦索希宾-1表达通过抑制微管活动增加了卵巢癌的帕克利塔塞尔敏感性
Takahiro Koyanagi1, Yasushi Saga1,2, Yoshifumi Takahashi1
1Department of Obstetrics and Gynecology, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Cancer reports (Hoboken, N.J.)
|December 22, 2024
概括
瓦索希宾-1 (VASH1) 增强了帕克利塔克塞尔化学疗法在卵巢癌中的有效性,通过增加被氧化氨酸氨酸和环素B1. 准VASH1可能会改善卵巢癌治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 瓦索希宾-1 (VASH1) 是一种血管性抑制剂,具有影响微管功能的林碳氧酶活性.
- 帕克利塔塞尔是一种主要的卵巢癌化疗,向微管,可能与VASH1.1相互作用.
研究的目的:
- 为了研究VASH1对素异化,环林B1表达和帕克利塔塞尔化学敏感性的影响.
- 在这些研究中利用VASH1-过度表达的卵巢癌细胞系.
主要方法:
- 在基因移植的人类卵巢癌细胞系上进行了西斑分析.
- 使用WST-1试验评估细胞活力,以确定化学敏感性.
主要成果:
- 在VASH1的过度表达上调了tasiosinated tubulin和cyclin B1的表达.
- 在VASH1过度表达细胞中,帕克利塔塞尔的化学敏感性显著增强,与西斯的敏感性不同.
- VASH1增强了素碳氧酶活性,增加了环林B1和帕克利塔塞尔的敏感性.
结论:
- 在卵巢癌中准VASH1可以增强化疗效.
- VASH1影响血管生成和微管活动,提供治疗潜力.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Destabilization of Microtubules
2.6K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


